These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12057621)

  • 41. Detection of measles vaccine in the throat of a vaccinated child.
    Morfin F; Beguin A; Lina B; Thouvenot D
    Vaccine; 2002 Feb; 20(11-12):1541-3. PubMed ID: 11858860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy evaluation of measles vaccine in fields].
    Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):292-4. PubMed ID: 1782660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunization of children with attenuated measles-rubella bivalent vaccine.
    Ramos-Alvarez M; Miller BH; Jackson JE; Schwarz AJ; Bessudo L
    Am J Dis Child; 1975 Apr; 129(4):474-7. PubMed ID: 1093389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measles immunization: new recommendation.
    Krugman S
    JAMA; 1977 Jan; 237(4):366. PubMed ID: 576171
    [No Abstract]   [Full Text] [Related]  

  • 46. Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation.
    Shinjoh M; Hoshino K; Takahashi T; Nakayama T
    Vaccine; 2015 Jan; 33(5):701-7. PubMed ID: 25510391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serological methods of detecting antibodies against the measles virus: use of the ELISA immunoenzyme technic].
    Rapicetta M; Proietti E; Morace G; Rozera C; Macchia T
    Ann Ist Super Sanita; 1982; 18(3):525-8. PubMed ID: 7187839
    [No Abstract]   [Full Text] [Related]  

  • 48. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies.
    Makino S; Sasaki K; Nakayama T; Oka S; Urano T; Kimura M; Kawana R; Yamamura AM
    Am J Dis Child; 1990 Aug; 144(8):905-10. PubMed ID: 2198807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measles vaccination: new strategies and formulations.
    de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL
    Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Seroconversion study of Biken CAM-70 measles vaccine formulations].
    Camacho LA; Freire MS; Yamamura AM; da Luz Leal M; Mann G
    Rev Saude Publica; 2000 Aug; 34(4):358-66. PubMed ID: 10973155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effectiveness of measles inoculations in the Hungarian People's Republic].
    Erdös L
    Tr Inst Im Pastera; 1979; 53():19-25. PubMed ID: 262709
    [No Abstract]   [Full Text] [Related]  

  • 53. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.
    Ajjan N; Fayet MT; Biron G; Charbonnier C; Nicolas A; Triau R; Roumiantzeff M
    Dev Biol Stand; 1978; 41():209-16. PubMed ID: 111980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I; Peltola H; Leinikki P; Valle M
    Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dry powder measles vaccine: particle deposition, virus replication, and immune response in cotton rats following inhalation.
    Kisich KO; Higgins MP; Park I; Cape SP; Lindsay L; Bennett DJ; Winston S; Searles J; Sievers RE
    Vaccine; 2011 Jan; 29(5):905-12. PubMed ID: 20974303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.
    Yee JL; ; McChesney MB; Christe KL
    Comp Med; 2015 Oct; 65(5):448-54. PubMed ID: 26473350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
    Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
    Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measles vaccine: a 27-year follow-up.
    Ramsay ME; Moffatt D; O'Connor M
    Epidemiol Infect; 1994 Apr; 112(2):409-12. PubMed ID: 8150015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Live measles vaccine: a 21 year follow up.
    Miller C
    Br Med J (Clin Res Ed); 1987 Jul; 295(6589):22-4. PubMed ID: 3113599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.